FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37733911000001100: Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1804201000001118 Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1804221000001113 Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Has AMP Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Is a Lanadelumab 300mg/2ml solution for injection vials 1 vial true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Has specific active ingredient Lanadelumab false Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Has specific active ingredient Lanadelumab true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start